Literature DB >> 22627260

Spicy seizure.

Sadip Pant1, Abhishek Deshmukh, Bhagirath Dholaria, Varinder Kaur, Samayuktha Ramavaram, Mary Ukor, Gerson A Teran.   

Abstract

Despite the widespread use of illegal synthetic cannabinoids, report of serious toxicity following its use of is rare. The authors report a case of severe toxicity after intentional inhalation of the synthetic cannabinoid JWH-018.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22627260     DOI： 10.1097/MAJ.0b013e31824cf5c2

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN： 0002-9629            Impact factor:   2.378


  10 in total

1.  Synthetic Cannabinoids: Pharmacology, Behavioral Effects, and Abuse Potential.

Authors:  Sherrica Tai; William E Fantegrossi
Journal:  Curr Addict Rep       Date:  2014-06-01

Review 2.  Spicing things up: synthetic cannabinoids.

Authors:  Max Spaderna; Peter H Addy; Deepak Cyril D'Souza
Journal:  Psychopharmacology (Berl)       Date:  2013-07-09       Impact factor: 4.530

3.  Structure-activity relationships of valine, tert-leucine, and phenylalanine amino acid-derived synthetic cannabinoid receptor agonists related to ADB-BUTINACA, APP-BUTINACA, and ADB-P7AICA.

Authors:  Eric Sparkes; Elizabeth A Cairns; Richard C Kevin; Felcia Lai; Katharina Elisabeth Grafinger; Shuli Chen; Marie H Deventer; Ross Ellison; Rochelle Boyd; Lewis J Martin; Iain S McGregor; Roy R Gerona; David E Hibbs; Volker Auwärter; Michelle Glass; Christophe Stove; Samuel D Banister
Journal:  RSC Med Chem       Date:  2021-10-25

4.  Ischemic stroke after use of the synthetic marijuana "spice".

Authors:  Melissa J Freeman; David Z Rose; Martin A Myers; Clifton L Gooch; Andrea C Bozeman; W Scott Burgin
Journal:  Neurology       Date:  2013-11-08       Impact factor: 9.910

5.  Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands.

Authors:  Krishna C Chimalakonda; Kathryn A Seely; Stacie M Bratton; Lisa K Brents; Cindy L Moran; Gregory W Endres; Laura P James; Paul F Hollenberg; Paul L Prather; Anna Radominska-Pandya; Jeffery H Moran
Journal:  Drug Metab Dispos       Date:  2012-08-17       Impact factor: 3.922

Review 6.  Cannabinoids and Epilepsy.

Authors:  Evan C Rosenberg; Richard W Tsien; Benjamin J Whalley; Orrin Devinsky
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

Review 7.  Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.

Authors:  Marisol S Castaneto; David A Gorelick; Nathalie A Desrosiers; Rebecca L Hartman; Sandrine Pirard; Marilyn A Huestis
Journal:  Drug Alcohol Depend       Date:  2014-08-18       Impact factor: 4.492

8.  A Common Source Outbreak of Severe Delirium Associated with Exposure to the Novel Synthetic Cannabinoid ADB-PINACA.

Authors:  Michael D Schwartz; Jordan Trecki; Laura A Edison; Alaina R Steck; Justin K Arnold; Roy R Gerona
Journal:  J Emerg Med       Date:  2015-02-26       Impact factor: 1.473

9.  Synthesis and pharmacological evaluation of newly detected synthetic cannabinoid receptor agonists AB-4CN-BUTICA, MMB-4CN-BUTINACA, MDMB-4F-BUTICA, MDMB-4F-BUTINACA and their analogs.

Authors:  Eric Sparkes; Rochelle Boyd; Shuli Chen; Jack W Markham; Jia Lin Luo; Tahira Foyzun; Humayra Zaman; Charlotte Fletcher; Ross Ellison; Iain S McGregor; Marina J Santiago; Felcia Lai; Roy R Gerona; Mark Connor; David E Hibbs; Elizabeth A Cairns; Michelle Glass; Adam Ametovski; Samuel D Banister
Journal:  Front Psychiatry       Date:  2022-09-28       Impact factor: 5.435

Review 10.  Designer drugs: mechanism of action and adverse effects.

Authors:  Dino Luethi; Matthias E Liechti
Journal:  Arch Toxicol       Date:  2020-04-06       Impact factor: 5.153
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.